{"entity":{"type":"insider","cik":"0001635111","url":"/insider/0001635111","json_url":"/insider/0001635111.json","name":"Bright Lisa","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":37,"n_filings":29,"first":"2015-11-30","last":"2019-10-31","span_basis":"filed_date"},"name_variants":[{"name":"Bright Lisa","source":"filing","n_filings":29,"first_seen":"2015-11-30","last_seen":"2019-10-31"}],"transactions":[{"id":8441463,"accession":"0001104659-19-058533","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-19-058533","line_url":"/filing/0001104659-19-058533#line-1","is_derivative":false,"issuer_cik":"0001270073","issuer_name":"INTERCEPT PHARMACEUTICALS, INC.","issuer_ticker":"ICPT","issuer_name_source":null,"issuer_url":"/issuer/0001270073","owner_cik":"0001635111","owner_name":"Bright Lisa","owner_display_name":"Bright Lisa","owner_url":"/insider/0001635111","role":"Officer (President, International)","role_mark":"O","role_mark_label":"Officer (President, International)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, International","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":595.0,"shares_display":"595","price_per_share":75.0,"price_display":"75.00","price_state":"stated","total_value":44625.0,"total_display":"44,625.00","total_whole":"44,625","shares_owned_after":18732.0,"shares_owned_after_display":"18,732","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-10-29","filed_date":"2019-10-31","scope":"insider"},{"id":7845044,"accession":"0001144204-19-033813","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001144204-19-033813","line_url":"/filing/0001144204-19-033813#line-2","is_derivative":false,"issuer_cik":"0001270073","issuer_name":"INTERCEPT PHARMACEUTICALS, INC.","issuer_ticker":"ICPT","issuer_name_source":null,"issuer_url":"/issuer/0001270073","owner_cik":"0001635111","owner_name":"Bright Lisa","owner_display_name":"Bright Lisa","owner_url":"/insider/0001635111","role":"Officer (President, International)","role_mark":"O","role_mark_label":"Officer (President, International)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, International","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":595.0,"shares_display":"595","price_per_share":78.66,"price_display":"78.66","price_state":"stated","total_value":46802.7,"total_display":"46,802.70","total_whole":"46,803","shares_owned_after":19857.0,"shares_owned_after_display":"19,857","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-07-03","filed_date":"2019-07-03","scope":"insider"},{"id":8482467,"accession":"0001144204-19-018076","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001144204-19-018076","line_url":"/filing/0001144204-19-018076#line-2","is_derivative":false,"issuer_cik":"0001270073","issuer_name":"INTERCEPT PHARMACEUTICALS, INC.","issuer_ticker":"ICPT","issuer_name_source":null,"issuer_url":"/issuer/0001270073","owner_cik":"0001635111","owner_name":"Bright Lisa","owner_display_name":"Bright Lisa","owner_url":"/insider/0001635111","role":"Officer (President, International)","role_mark":"O","role_mark_label":"Officer (President, International)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, International","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":594.0,"shares_display":"594","price_per_share":115.01,"price_display":"115.01","price_state":"stated","total_value":68315.94,"total_display":"68,315.94","total_whole":"68,316","shares_owned_after":20982.0,"shares_owned_after_display":"20,982","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-04-03","filed_date":"2019-04-03","scope":"insider"},{"id":8769709,"accession":"0001144204-19-001262","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-19-001262","line_url":"/filing/0001144204-19-001262#line-1","is_derivative":false,"issuer_cik":"0001270073","issuer_name":"INTERCEPT PHARMACEUTICALS, INC.","issuer_ticker":"ICPT","issuer_name_source":null,"issuer_url":"/issuer/0001270073","owner_cik":"0001635111","owner_name":"Bright Lisa","owner_display_name":"Bright Lisa","owner_url":"/insider/0001635111","role":"Officer (President, International)","role_mark":"O","role_mark_label":"Officer (President, International)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, International","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1313.0,"shares_display":"1,313","price_per_share":104.93,"price_display":"104.93","price_state":"stated","total_value":137773.09,"total_display":"137,773.09","total_whole":"137,773","shares_owned_after":18807.0,"shares_owned_after_display":"18,807","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-01-07","filed_date":"2019-01-09","scope":"insider"},{"id":6390904,"accession":"0001144204-18-063432","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001144204-18-063432","line_url":"/filing/0001144204-18-063432#line-4","is_derivative":false,"issuer_cik":"0001270073","issuer_name":"INTERCEPT PHARMACEUTICALS, INC.","issuer_ticker":"ICPT","issuer_name_source":null,"issuer_url":"/issuer/0001270073","owner_cik":"0001635111","owner_name":"Bright Lisa","owner_display_name":"Bright Lisa","owner_url":"/insider/0001635111","role":"Officer (President, International)","role_mark":"O","role_mark_label":"Officer (President, International)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, International","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300.0,"shares_display":"300","price_per_share":111.0,"price_display":"111.00","price_state":"stated","total_value":33300.0,"total_display":"33,300.00","total_whole":"33,300","shares_owned_after":21288.0,"shares_owned_after_display":"21,288","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-12-04","filed_date":"2018-12-06","scope":"insider"},{"id":6390901,"accession":"0001144204-18-063432","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001144204-18-063432","line_url":"/filing/0001144204-18-063432","is_derivative":false,"issuer_cik":"0001270073","issuer_name":"INTERCEPT PHARMACEUTICALS, INC.","issuer_ticker":"ICPT","issuer_name_source":null,"issuer_url":"/issuer/0001270073","owner_cik":"0001635111","owner_name":"Bright Lisa","owner_display_name":"Bright Lisa","owner_url":"/insider/0001635111","role":"Officer (President, International)","role_mark":"O","role_mark_label":"Officer (President, International)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, International","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4700.0,"shares_display":"4,700","price_per_share":111.45135106382979,"price_display":"111.45","price_state":"stated","total_value":523821.35,"total_display":"523,821.35","total_whole":"523,821","shares_owned_after":22488.0,"shares_owned_after_display":"22,488","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-12-03","filed_date":"2018-12-06","scope":"insider","n_lines":3},{"id":5023326,"accession":"0001144204-17-051415","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-17-051415","line_url":"/filing/0001144204-17-051415#line-1","is_derivative":false,"issuer_cik":"0001270073","issuer_name":"INTERCEPT PHARMACEUTICALS INC","issuer_ticker":"ICPT","issuer_name_source":null,"issuer_url":"/issuer/0001270073","owner_cik":"0001635111","owner_name":"Bright Lisa","owner_display_name":"Bright Lisa","owner_url":"/insider/0001635111","role":"Officer (President International)","role_mark":"O","role_mark_label":"Officer (President International)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President International","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":390.0,"shares_display":"390","price_per_share":58.922,"price_display":"58.92","price_state":"stated","total_value":22979.58,"total_display":"22,979.58","total_whole":"22,980","shares_owned_after":22834.0,"shares_owned_after_display":"22,834","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-10-02","filed_date":"2017-10-04","scope":"insider"},{"id":4190879,"accession":"0001144204-17-045730","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001144204-17-045730","line_url":"/filing/0001144204-17-045730","is_derivative":false,"issuer_cik":"0001270073","issuer_name":"INTERCEPT PHARMACEUTICALS INC","issuer_ticker":"ICPT","issuer_name_source":null,"issuer_url":"/issuer/0001270073","owner_cik":"0001635111","owner_name":"Bright Lisa","owner_display_name":"Bright Lisa","owner_url":"/insider/0001635111","role":"Officer (President International)","role_mark":"O","role_mark_label":"Officer (President International)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President International","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":253.0,"shares_display":"253","price_per_share":111.30960316205534,"price_display":"111.31","price_state":"stated","total_value":28161.3296,"total_display":"28,161.33","total_whole":"28,161","shares_owned_after":23324.0,"shares_owned_after_display":"23,324","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-08-25","filed_date":"2017-08-29","scope":"insider","n_lines":2},{"id":4595014,"accession":"0001144204-17-040074","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-17-040074","line_url":"/filing/0001144204-17-040074#line-1","is_derivative":false,"issuer_cik":"0001270073","issuer_name":"INTERCEPT PHARMACEUTICALS INC","issuer_ticker":"ICPT","issuer_name_source":null,"issuer_url":"/issuer/0001270073","owner_cik":"0001635111","owner_name":"Bright Lisa","owner_display_name":"Bright Lisa","owner_url":"/insider/0001635111","role":"Officer (President International)","role_mark":"O","role_mark_label":"Officer (President International)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President International","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":142.0,"shares_display":"142","price_per_share":110.2868,"price_display":"110.29","price_state":"stated","total_value":15660.7256,"total_display":"15,660.73","total_whole":"15,661","shares_owned_after":23477.0,"shares_owned_after_display":"23,477","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-08-02","filed_date":"2017-08-02","scope":"insider"},{"id":5298662,"accession":"0001144204-17-035809","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-17-035809","line_url":"/filing/0001144204-17-035809#line-1","is_derivative":false,"issuer_cik":"0001270073","issuer_name":"INTERCEPT PHARMACEUTICALS INC","issuer_ticker":"ICPT","issuer_name_source":null,"issuer_url":"/issuer/0001270073","owner_cik":"0001635111","owner_name":"Bright Lisa","owner_display_name":"Bright Lisa","owner_url":"/insider/0001635111","role":"Officer (President International)","role_mark":"O","role_mark_label":"Officer (President International)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President International","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":394.0,"shares_display":"394","price_per_share":121.325,"price_display":"121.32","price_state":"stated","total_value":47802.05,"total_display":"47,802.05","total_whole":"47,802","shares_owned_after":23619.0,"shares_owned_after_display":"23,619","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-07-03","filed_date":"2017-07-05","scope":"insider"},{"id":4459741,"accession":"0001144204-17-030905","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001144204-17-030905","line_url":"/filing/0001144204-17-030905","is_derivative":false,"issuer_cik":"0001270073","issuer_name":"INTERCEPT PHARMACEUTICALS INC","issuer_ticker":"ICPT","issuer_name_source":null,"issuer_url":"/issuer/0001270073","owner_cik":"0001635111","owner_name":"Bright Lisa","owner_display_name":"Bright Lisa","owner_url":"/insider/0001635111","role":"Officer (President International)","role_mark":"O","role_mark_label":"Officer (President International)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President International","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":698.0,"shares_display":"698","price_per_share":110.7288653295129,"price_display":"110.73","price_state":"stated","total_value":77288.748,"total_display":"77,288.75","total_whole":"77,289","shares_owned_after":24163.0,"shares_owned_after_display":"24,163","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-06-01","filed_date":"2017-06-02","scope":"insider","n_lines":3},{"id":4819313,"accession":"0001144204-17-030259","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-17-030259","line_url":"/filing/0001144204-17-030259#line-1","is_derivative":false,"issuer_cik":"0001270073","issuer_name":"INTERCEPT PHARMACEUTICALS INC","issuer_ticker":"ICPT","issuer_name_source":null,"issuer_url":"/issuer/0001270073","owner_cik":"0001635111","owner_name":"Bright Lisa","owner_display_name":"Bright Lisa","owner_url":"/insider/0001635111","role":"Officer (President International)","role_mark":"O","role_mark_label":"Officer (President International)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President International","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":254.0,"shares_display":"254","price_per_share":117.5207,"price_display":"117.52","price_state":"stated","total_value":29850.2578,"total_display":"29,850.26","total_whole":"29,850","shares_owned_after":23246.0,"shares_owned_after_display":"23,246","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-05-25","filed_date":"2017-05-30","scope":"insider"},{"id":4594844,"accession":"0001144204-17-028507","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001144204-17-028507","line_url":"/filing/0001144204-17-028507","is_derivative":false,"issuer_cik":"0001270073","issuer_name":"INTERCEPT PHARMACEUTICALS INC","issuer_ticker":"ICPT","issuer_name_source":null,"issuer_url":"/issuer/0001270073","owner_cik":"0001635111","owner_name":"Bright Lisa","owner_display_name":"Bright Lisa","owner_url":"/insider/0001635111","role":"Officer (President International)","role_mark":"O","role_mark_label":"Officer (President International)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President International","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":113.0,"shares_display":"113","price_per_share":119.74153097345133,"price_display":"119.74","price_state":"stated","total_value":13530.793,"total_display":"13,530.79","total_whole":"13,531","shares_owned_after":23500.0,"shares_owned_after_display":"23,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-05-16","filed_date":"2017-05-18","scope":"insider","n_lines":2},{"id":4237454,"accession":"0001144204-17-026210","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001144204-17-026210","line_url":"/filing/0001144204-17-026210#line-2","is_derivative":false,"issuer_cik":"0001270073","issuer_name":"INTERCEPT PHARMACEUTICALS INC","issuer_ticker":"ICPT","issuer_name_source":null,"issuer_url":"/issuer/0001270073","owner_cik":"0001635111","owner_name":"Bright Lisa","owner_display_name":"Bright Lisa","owner_url":"/insider/0001635111","role":"Officer (President International)","role_mark":"O","role_mark_label":"Officer (President International)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President International","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":426.0,"shares_display":"426","price_per_share":114.0,"price_display":"114.00","price_state":"stated","total_value":48564.0,"total_display":"48,564.00","total_whole":"48,564","shares_owned_after":23378.0,"shares_owned_after_display":"23,378","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-05-02","filed_date":"2017-05-10","scope":"insider"},{"id":4237401,"accession":"0001144204-17-019296","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-17-019296","line_url":"/filing/0001144204-17-019296#line-1","is_derivative":false,"issuer_cik":"0001270073","issuer_name":"INTERCEPT PHARMACEUTICALS INC","issuer_ticker":"ICPT","issuer_name_source":null,"issuer_url":"/issuer/0001270073","owner_cik":"0001635111","owner_name":"Bright Lisa","owner_display_name":"Bright Lisa","owner_url":"/insider/0001635111","role":"Officer (President International)","role_mark":"O","role_mark_label":"Officer (President International)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President International","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":389.0,"shares_display":"389","price_per_share":114.9973,"price_display":"115.00","price_state":"stated","total_value":44733.9497,"total_display":"44,733.95","total_whole":"44,734","shares_owned_after":22925.0,"shares_owned_after_display":"22,925","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-04-03","filed_date":"2017-04-05","scope":"insider"},{"id":4673510,"accession":"0001144204-17-013072","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001144204-17-013072","line_url":"/filing/0001144204-17-013072#line-2","is_derivative":false,"issuer_cik":"0001270073","issuer_name":"INTERCEPT PHARMACEUTICALS INC","issuer_ticker":"ICPT","issuer_name_source":null,"issuer_url":"/issuer/0001270073","owner_cik":"0001635111","owner_name":"Bright Lisa","owner_display_name":"Bright Lisa","owner_url":"/insider/0001635111","role":"Officer (President International)","role_mark":"O","role_mark_label":"Officer (President International)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President International","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1313.0,"shares_display":"1,313","price_per_share":130.1626,"price_display":"130.16","price_state":"stated","total_value":170903.4938,"total_display":"170,903.49","total_whole":"170,903","shares_owned_after":23314.0,"shares_owned_after_display":"23,314","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-03-02","filed_date":"2017-03-06","scope":"insider"},{"id":4789147,"accession":"0001144204-17-012807","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001144204-17-012807","line_url":"/filing/0001144204-17-012807#line-2","is_derivative":false,"issuer_cik":"0001270073","issuer_name":"INTERCEPT PHARMACEUTICALS INC","issuer_ticker":"ICPT","issuer_name_source":null,"issuer_url":"/issuer/0001270073","owner_cik":"0001635111","owner_name":"Bright Lisa","owner_display_name":"Bright Lisa","owner_url":"/insider/0001635111","role":"Officer (President International)","role_mark":"O","role_mark_label":"Officer (President International)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President International","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":136.0,"shares_display":"136","price_per_share":130.16,"price_display":"130.16","price_state":"stated","total_value":17701.76,"total_display":"17,701.76","total_whole":"17,702","shares_owned_after":21813.0,"shares_owned_after_display":"21,813","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-03-01","filed_date":"2017-03-03","scope":"insider"},{"id":5022599,"accession":"0001144204-17-012274","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-17-012274","line_url":"/filing/0001144204-17-012274#line-1","is_derivative":false,"issuer_cik":"0001270073","issuer_name":"INTERCEPT PHARMACEUTICALS INC","issuer_ticker":"ICPT","issuer_name_source":null,"issuer_url":"/issuer/0001270073","owner_cik":"0001635111","owner_name":"Bright Lisa","owner_display_name":"Bright Lisa","owner_url":"/insider/0001635111","role":"Officer (President International)","role_mark":"O","role_mark_label":"Officer (President International)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President International","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":254.0,"shares_display":"254","price_per_share":119.48,"price_display":"119.48","price_state":"stated","total_value":30347.92,"total_display":"30,347.92","total_whole":"30,348","shares_owned_after":21695.0,"shares_owned_after_display":"21,695","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-02-27","filed_date":"2017-03-01","scope":"insider"},{"id":4373019,"accession":"0001144204-17-005736","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001144204-17-005736","line_url":"/filing/0001144204-17-005736#line-2","is_derivative":false,"issuer_cik":"0001270073","issuer_name":"INTERCEPT PHARMACEUTICALS INC","issuer_ticker":"ICPT","issuer_name_source":null,"issuer_url":"/issuer/0001270073","owner_cik":"0001635111","owner_name":"Bright Lisa","owner_display_name":"Bright Lisa","owner_url":"/insider/0001635111","role":"Officer (President International)","role_mark":"O","role_mark_label":"Officer (President International)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President International","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":134.0,"shares_display":"134","price_per_share":108.96,"price_display":"108.96","price_state":"stated","total_value":14600.64,"total_display":"14,600.64","total_whole":"14,601","shares_owned_after":17249.0,"shares_owned_after_display":"17,249","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-01-31","filed_date":"2017-02-02","scope":"insider"},{"id":4126976,"accession":"0001144204-17-000941","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-17-000941","line_url":"/filing/0001144204-17-000941#line-1","is_derivative":false,"issuer_cik":"0001270073","issuer_name":"INTERCEPT PHARMACEUTICALS INC","issuer_ticker":"ICPT","issuer_name_source":null,"issuer_url":"/issuer/0001270073","owner_cik":"0001635111","owner_name":"Bright Lisa","owner_display_name":"Bright Lisa","owner_url":"/insider/0001635111","role":"Officer (President International)","role_mark":"O","role_mark_label":"Officer (President International)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President International","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1119.0,"shares_display":"1,119","price_per_share":103.9191,"price_display":"103.92","price_state":"stated","total_value":116285.4729,"total_display":"116,285.47","total_whole":"116,285","shares_owned_after":17090.0,"shares_owned_after_display":"17,090","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-01-03","filed_date":"2017-01-05","scope":"insider"},{"id":2451380,"accession":"0001144204-16-137066","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-16-137066","line_url":"/filing/0001144204-16-137066#line-1","is_derivative":false,"issuer_cik":"0001270073","issuer_name":"INTERCEPT PHARMACEUTICALS INC","issuer_ticker":"ICPT","issuer_name_source":null,"issuer_url":"/issuer/0001270073","owner_cik":"0001635111","owner_name":"Bright Lisa","owner_display_name":"Bright Lisa","owner_url":"/insider/0001635111","role":"Officer (President International)","role_mark":"O","role_mark_label":"Officer (President International)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President International","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":249.0,"shares_display":"249","price_per_share":113.5994,"price_display":"113.60","price_state":"stated","total_value":28286.2506,"total_display":"28,286.25","total_whole":"28,286","shares_owned_after":18209.0,"shares_owned_after_display":"18,209","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-11-25","filed_date":"2016-11-29","scope":"insider"},{"id":3284716,"accession":"0001144204-16-135250","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001144204-16-135250","line_url":"/filing/0001144204-16-135250#line-2","is_derivative":false,"issuer_cik":"0001270073","issuer_name":"INTERCEPT PHARMACEUTICALS INC","issuer_ticker":"ICPT","issuer_name_source":null,"issuer_url":"/issuer/0001270073","owner_cik":"0001635111","owner_name":"Bright Lisa","owner_display_name":"Bright Lisa","owner_url":"/insider/0001635111","role":"Officer (President International)","role_mark":"O","role_mark_label":"Officer (President International)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President International","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":140.0,"shares_display":"140","price_per_share":112.2736,"price_display":"112.27","price_state":"stated","total_value":15718.304,"total_display":"15,718.30","total_whole":"15,718","shares_owned_after":18458.0,"shares_owned_after_display":"18,458","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-11-15","filed_date":"2016-11-17","scope":"insider"},{"id":3226383,"accession":"0001144204-16-127096","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-16-127096","line_url":"/filing/0001144204-16-127096#line-1","is_derivative":false,"issuer_cik":"0001270073","issuer_name":"INTERCEPT PHARMACEUTICALS INC","issuer_ticker":"ICPT","issuer_name_source":null,"issuer_url":"/issuer/0001270073","owner_cik":"0001635111","owner_name":"Bright Lisa","owner_display_name":"Bright Lisa","owner_url":"/insider/0001635111","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":155.0,"shares_display":"155","price_per_share":163.1997,"price_display":"163.20","price_state":"stated","total_value":25295.9535,"total_display":"25,295.95","total_whole":"25,296","shares_owned_after":18305.0,"shares_owned_after_display":"18,305","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-10-03","filed_date":"2016-10-05","scope":"insider"},{"id":2671891,"accession":"0001144204-16-121290","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-16-121290","line_url":"/filing/0001144204-16-121290#line-1","is_derivative":false,"issuer_cik":"0001270073","issuer_name":"INTERCEPT PHARMACEUTICALS INC","issuer_ticker":"ICPT","issuer_name_source":null,"issuer_url":"/issuer/0001270073","owner_cik":"0001635111","owner_name":"Bright Lisa","owner_display_name":"Bright Lisa","owner_url":"/insider/0001635111","role":"Officer (President of International)","role_mark":"O","role_mark_label":"Officer (President of International)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President of International","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":246.0,"shares_display":"246","price_per_share":159.0,"price_display":"159.00","price_state":"stated","total_value":39114.0,"total_display":"39,114.00","total_whole":"39,114","shares_owned_after":18460.0,"shares_owned_after_display":"18,460","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-08-25","filed_date":"2016-08-25","scope":"insider"},{"id":2477538,"accession":"0001144204-16-112097","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-16-112097","line_url":"/filing/0001144204-16-112097#line-1","is_derivative":false,"issuer_cik":"0001270073","issuer_name":"INTERCEPT PHARMACEUTICALS INC","issuer_ticker":"ICPT","issuer_name_source":null,"issuer_url":"/issuer/0001270073","owner_cik":"0001635111","owner_name":"Bright Lisa","owner_display_name":"Bright Lisa","owner_url":"/insider/0001635111","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":155.0,"shares_display":"155","price_per_share":145.1092,"price_display":"145.11","price_state":"stated","total_value":22491.926,"total_display":"22,491.93","total_whole":"22,492","shares_owned_after":18706.0,"shares_owned_after_display":"18,706","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-07-05","filed_date":"2016-07-07","scope":"insider"},{"id":2565825,"accession":"0001144204-16-105286","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-16-105286","line_url":"/filing/0001144204-16-105286#line-1","is_derivative":false,"issuer_cik":"0001270073","issuer_name":"INTERCEPT PHARMACEUTICALS INC","issuer_ticker":"ICPT","issuer_name_source":null,"issuer_url":"/issuer/0001270073","owner_cik":"0001635111","owner_name":"Bright Lisa","owner_display_name":"Bright Lisa","owner_url":"/insider/0001635111","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":251.0,"shares_display":"251","price_per_share":137.4978,"price_display":"137.50","price_state":"stated","total_value":34511.9478,"total_display":"34,511.95","total_whole":"34,512","shares_owned_after":18855.0,"shares_owned_after_display":"18,855","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-05-25","filed_date":"2016-05-26","scope":"insider"},{"id":3048281,"accession":"0001144204-16-093109","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-16-093109","line_url":"/filing/0001144204-16-093109#line-1","is_derivative":false,"issuer_cik":"0001270073","issuer_name":"INTERCEPT PHARMACEUTICALS INC","issuer_ticker":"ICPT","issuer_name_source":null,"issuer_url":"/issuer/0001270073","owner_cik":"0001635111","owner_name":"Bright Lisa","owner_display_name":"Bright Lisa","owner_url":"/insider/0001635111","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":153.0,"shares_display":"153","price_per_share":130.76,"price_display":"130.76","price_state":"stated","total_value":20006.28,"total_display":"20,006.28","total_whole":"20,006","shares_owned_after":19106.0,"shares_owned_after_display":"19,106","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-04-04","filed_date":"2016-04-06","scope":"insider"},{"id":2609961,"accession":"0001144204-16-085089","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-16-085089","line_url":"/filing/0001144204-16-085089#line-1","is_derivative":false,"issuer_cik":"0001270073","issuer_name":"INTERCEPT PHARMACEUTICALS INC","issuer_ticker":"ICPT","issuer_name_source":null,"issuer_url":"/issuer/0001270073","owner_cik":"0001635111","owner_name":"Bright Lisa","owner_display_name":"Bright Lisa","owner_url":"/insider/0001635111","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":241.0,"shares_display":"241","price_per_share":115.2198,"price_display":"115.22","price_state":"stated","total_value":27767.9718,"total_display":"27,767.97","total_whole":"27,768","shares_owned_after":19259.0,"shares_owned_after_display":"19,259","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-02-25","filed_date":"2016-02-29","scope":"insider"},{"id":2911832,"accession":"0001144204-16-075725","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001144204-16-075725","line_url":"/filing/0001144204-16-075725#line-2","is_derivative":false,"issuer_cik":"0001270073","issuer_name":"INTERCEPT PHARMACEUTICALS INC","issuer_ticker":"ICPT","issuer_name_source":null,"issuer_url":"/issuer/0001270073","owner_cik":"0001635111","owner_name":"Bright Lisa","owner_display_name":"Bright Lisa","owner_url":"/insider/0001635111","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":104.0,"shares_display":"104","price_per_share":129.9888,"price_display":"129.99","price_state":"stated","total_value":13518.8352,"total_display":"13,518.84","total_whole":"13,519","shares_owned_after":11700.0,"shares_owned_after_display":"11,700","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-01-13","filed_date":"2016-01-14","scope":"insider"},{"id":2911829,"accession":"0001144204-16-075725","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-16-075725","line_url":"/filing/0001144204-16-075725#line-1","is_derivative":false,"issuer_cik":"0001270073","issuer_name":"INTERCEPT PHARMACEUTICALS INC","issuer_ticker":"ICPT","issuer_name_source":null,"issuer_url":"/issuer/0001270073","owner_cik":"0001635111","owner_name":"Bright Lisa","owner_display_name":"Bright Lisa","owner_url":"/insider/0001635111","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":624.0,"shares_display":"624","price_per_share":124.7788,"price_display":"124.78","price_state":"stated","total_value":77861.9712,"total_display":"77,861.97","total_whole":"77,862","shares_owned_after":11804.0,"shares_owned_after_display":"11,804","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-01-12","filed_date":"2016-01-14","scope":"insider"},{"id":8365271,"accession":"0001144204-15-068675","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-15-068675","line_url":"/filing/0001144204-15-068675#line-1","is_derivative":false,"issuer_cik":"0001270073","issuer_name":"INTERCEPT PHARMACEUTICALS INC","issuer_ticker":"ICPT","issuer_name_source":null,"issuer_url":"/issuer/0001270073","owner_cik":"0001635111","owner_name":"Bright Lisa","owner_display_name":"Bright Lisa","owner_url":"/insider/0001635111","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1150.0,"shares_display":"1,150","price_per_share":182.9647,"price_display":"182.96","price_state":"stated","total_value":210409.405,"total_display":"210,409.40","total_whole":"210,409","shares_owned_after":12428.0,"shares_owned_after_display":"12,428","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-11-25","filed_date":"2015-11-30","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":37,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":37,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":37},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001270073","name":"INTERCEPT PHARMACEUTICALS, INC.","url":"/issuer/0001270073","role":"Officer (President, International)","n_filings":29,"first_seen":"2015-11-30","last_seen":"2019-10-31"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001635111","retrieved_at":"2026-08-23T13:11:01+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}